Sellas CEO Stergiou backs ‘rigorous, unblinded’ REGAL AML data
Sellas CEO Stergiou said rigorous, unblinded data from its pivotal AML trial will speak for itself as the REGAL catalyst nears.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.